The Sun Pharma is all set to buy Israel-drug maker Taro. The US Federal Trade Commission (FTC) has given its approval for the deal on certain conditions. The Mumbai-based drug maker Sun has to sell rights and assets of its anti-epilepsy drugs. Carbamazepine is a major anti-epilepsy brand prepared buy sun group. The Sun Pharma is ready to sell three distinct generic formulations to Torrent Pharmaceutical Ltd. Torrent Pharmaceutical Ltd is a major drug maker of Gujrat.

According to the research carried out by firm Gartner, the current global majors like IBM, EDS and Accenture are facing a major risk, if Tata Consultancy Services (TCS), Infosys Technologies and Wipro Technologies emerge as the nextgen IT service meagvendors.

Gartner said, “These (Indian) vendors are increasingly being considered for strategic service deals, and will augment or, in some cases, replace today’s acknowledged megavendors by revenue in this space by 2011.”

The report by Gartner said that the top Indian IT firms have defeated the megavendors by almost a 3:1 margin in growth rates.

Dell, which is a well known PC major, is hopeful that its India business would touch a billion dollars by next year.

Michael Dell, who is the Founder chairman and CEO of the company, was extremely excited about the growth in India, and had come to India for the launch of new ultra-portable business series laptops.

SE Investments Limited has i

New Delhi, Aug 14: The Union Cabinet today gave its approval for increasing the authorized capital of India Infrastructure Finance Company Limited (IIFCL) from Rs. 1000 crore to Rs. 2000 crore.

It will enhance the leveraging ability of IIFCL and would enable the Company to build a strong resource base alongwith higher net worth over a period of time.

IIFCL was incorporated on January 5, 2006, under the Companies Act 1956, as a wholly government owned company with an authorized capital of Rs. 1000 crore and paid-up capital of Rs. 300 crore.

‘Easy Five’, is a vaccine, which combats five infections diseases of early childhood.

Biotechnology firm Panacea Biotec has secured Rs 143 crore-contract from the United Nations Children’s Fund (UNICEF) for supplying this vaccine.  

Panacea Biotec is the first Indian pharmaceutical company to get this order from UNICEF for its vaccines in fully liquid form, the company informed the Bombay Stock Exchange.  

The order starts in 2008 and would continue till 2009.